![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Draft Guidance Outlines Procedure for Clinical Evaluation of Software as a Medical Device
Draft Guidance Outlines Procedure for Clinical Evaluation of Software as a Medical Device
![](https://www.fdanews.com/ext/resources/test/Device_Images/monitor.gif?t=1433878525&width=430)
The International Medical Device Regulators Forum has developed guidance outlining the steps required to generate clinical evidence of effectiveness and safety of software as a medical device (SaMD).
The draft guidance, issued by the FDA for public comment, addresses stand-alone software designed to produce or extract data, including diagnostic information, in tandem with a medical device. SaMD is not part of a device, nor is it used to operate a device, and would run on general-purpose computing platforms.
The first step in generating evidence would be to determine whether the scientific validity of the SaMD is already well-known. If not, scientific validity evidence would need to be generated. — Jim Stimson
Upcoming Events
-
21Oct